Cocrystal Pharma COCP
NASDAQ COCP
$1.16 +0.02 (+1.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cocrystal Pharma (COCP) Price to Sales (2019 - 2026)

Updated

Cocrystal Pharma's Price to Sales came in at 10.89 for Q2 2026, up 39.1% from the prior quarter.

Analysis

Cocrystal Pharma (COCP) Price to Sales (2019 - 2026) Analysis & Trends

For FY2020, Cocrystal Pharma's Price to Sales was 37.29.

  • Going back by year, Price to Sales was 0.00 in FY2019.
  • The Q2 2026 figure represents the highest quarterly Price to Sales since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Cocrystal Pharma 15.72 Mn -6.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.89
Mar 31, 2026 7.83
Dec 31, 2020 37.29
Sep 30, 2020 25.44
Jun 30, 2020 41.51
Mar 31, 2020 15.19
Dec 31, 2019 0.00
Sep 30, 2019 10.48
API Access

Cocrystal Pharma Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=COCP&period=max&api_key=YOUR_API_KEY